Goals of chronic obstructive pulmonary disease management: a focused review for clinicians
- 3 December 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 31 (2) , 156-164
Abstract
Purpose of review: The diagnosis of chronic obstructive pulmonary disease (COPD) encompasses heterogeneous pathophysiological mechanisms which can shape an individual patient's experience. This paper reviews available therapeutic options for the clinician intending to individualize care toward patient goals. Recent findings: The contemporary targeted interventions for COPD include the novel phosphodiesterase inhibitor ensifentrine, the interleukin-4 receptor (IL4R alpha subunit) antibody dupilumab, augmentation therapy for alpha-1 antitrypsin deficiency. Other interventions promoting physical and mental well being include re-envisioned pulmonary rehabilitation, self-management, targeting of comorbidities such as sarcopenia, and virtual health coaching interventions to expand patient access. Opioids did not relieve dyspnea and did not change total step count. Summary: Advances in precision therapy are complemented by the discovery of novel pathophysiology pathways and behavioral and rehabilitation interventions as a holistic view of COPD management emerges. The management of COPD continues to evolve with new tools including precision medicine and individualized care. Comorbidities remain important determinants of health, yet their prevalence and impact are underestimated.Keywords
This publication has 100 references indexed in Scilit:
- Mechanisms of osteoporosis associated with chronic obstructive pulmonary diseaseJournal of Bone and Mineral Metabolism, 2024
- β-Blocker Use and Clinical Outcomes in Patients With COPD Following Acute Myocardial InfarctionJAMA Network Open, 2024
- Systematic review and meta-analysis of nutrient supplements for treating sarcopenia in people with chronic obstructive pulmonary diseaseAging Clinical and Experimental Research, 2024
- Effect of Regular, Low-Dose, Extended-release Morphine on Chronic Breathlessness in Chronic Obstructive Pulmonary DiseaseJAMA, 2022
- Dyspnea—When a Sensation Becomes a SymptomJAMA, 2022
- Screening for Lung CancerJAMA, 2021
- Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: a systematic review and meta‐analysisJournal of Cachexia, Sarcopenia and Muscle, 2020
- Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT StudyAdvances in Therapy, 2020
- Association Between Initiation of Pulmonary Rehabilitation After Hospitalization for COPD and 1-Year Survival Among Medicare BeneficiariesJAMA, 2020
- Effect of Home Noninvasive Ventilation With Oxygen Therapy vs Oxygen Therapy Alone on Hospital Readmission or Death After an Acute COPD ExacerbationJAMA, 2017